3751 GENES FOUND

Show / hide columns

XML | RDF | TSV | « prev | Page of 76 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BTKBruton agammaglobulinemia tyrosine kinaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
VesiclesTissue enhanced
BZRAP1Benzodiazepine receptor (peripheral) associated protein 1Plasma proteins
Predicted intracellular proteins
Expressed in all
C11orf30Chromosome 11 open reading frame 30Plasma proteins
Predicted intracellular proteins
NucleoplasmExpressed in all
C14orf39Chromosome 14 open reading frame 39Plasma proteins
Predicted intracellular proteins
Nucleus
Nucleoli
Tissue enriched
C17orf75Chromosome 17 open reading frame 75Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Golgi apparatus
Cytosol
Expressed in all
C19orf80Chromosome 19 open reading frame 80Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Nucleoplasm
Golgi apparatus
Group enriched
C1QAComplement component 1, q subcomponent, A chainDisease related genes
Plasma proteins
Predicted secreted proteins
Golgi apparatus
Cytosol
Expressed in all
C1QBComplement component 1, q subcomponent, B chainDisease related genes
Plasma proteins
Predicted secreted proteins
Expressed in all
C1QBPComplement component 1, q subcomponent binding proteinCancer-related genes
Plasma proteins
Predicted intracellular proteins
Transporters
Plasma membrane
Mitochondria
Expressed in all
C1QCComplement component 1, q subcomponent, C chainDisease related genes
Plasma proteins
Predicted secreted proteins
VesiclesExpressed in all
C1QL1Complement component 1, q subcomponent-like 1Plasma proteins
Predicted secreted proteins
Tissue enriched
C1QTNF3C1q and tumor necrosis factor related protein 3Plasma proteins
Predicted secreted proteins
Golgi apparatusTissue enhanced
C1QTNF7C1q and tumor necrosis factor related protein 7Plasma proteins
Predicted secreted proteins
Mixed
C1RComplement component 1, r subcomponentEnzymes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Nucleoplasm
Cytosol
Expressed in all
C1RLComplement component 1, r subcomponent-likeEnzymes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Microtubules
Cytosol
Expressed in all
C1SComplement component 1, s subcomponentDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
Nucleus
Cytosol
Expressed in all
C2Complement component 2Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
C3Complement component 3Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
C4AComplement component 4A (Rodgers blood group)Blood group antigen proteins
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
C4BComplement component 4B (Chido blood group)Blood group antigen proteins
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
C4BPAComplement component 4 binding protein, alphaPlasma proteins
Predicted secreted proteins
Group enriched
C4BPBComplement component 4 binding protein, betaPlasma proteins
Predicted secreted proteins
Group enriched
C5Complement component 5Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
C6Complement component 6Cancer-related genes
Disease related genes
Plasma proteins
Potential drug targets
Predicted secreted proteins
Transporters
Group enriched
C7Complement component 7Cancer-related genes
Disease related genes
Plasma proteins
Predicted secreted proteins
Tissue enhanced
C8AComplement component 8, alpha polypeptideDisease related genes
Plasma proteins
Potential drug targets
Predicted secreted proteins
Transporters
Tissue enriched
C8BComplement component 8, beta polypeptideDisease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
C8GComplement component 8, gamma polypeptidePlasma proteins
Predicted secreted proteins
Endoplasmic reticulumGroup enriched
C9Complement component 9Disease related genes
Plasma proteins
Predicted secreted proteins
Plasma membrane
Cytosol
Tissue enriched
C9orf3Chromosome 9 open reading frame 3Enzymes
Plasma proteins
Predicted intracellular proteins
Cell JunctionsExpressed in all
CA1Carbonic anhydrase IEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Group enriched
CA2Carbonic anhydrase IIDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enhanced
CA3Carbonic anhydrase IIIEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enriched
CAB39Calcium binding protein 39Plasma proteins
Predicted intracellular proteins
Nucleoli
Cytosol
Expressed in all
CAB39LCalcium binding protein 39-likePlasma proteins
Predicted intracellular proteins
VesiclesExpressed in all
CABIN1Calcineurin binding protein 1Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Aggresome
Cytosol
Expressed in all
CABLES1Cdk5 and Abl enzyme substrate 1Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Nuclear specklesTissue enhanced
CACNA1ACalcium channel, voltage-dependent, P/Q type, alpha 1A subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Golgi apparatus
Vesicles
Tissue enhanced
CACNA1BCalcium channel, voltage-dependent, N type, alpha 1B subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Group enriched
CACNA1DCalcium channel, voltage-dependent, L type, alpha 1D subunitCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Nuclear membraneMixed
CACNA1FCalcium channel, voltage-dependent, L type, alpha 1F subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
CACNA1GCalcium channel, voltage-dependent, T type, alpha 1G subunitFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
CACNA1ICalcium channel, voltage-dependent, T type, alpha 1I subunitFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
CACNA2D1Calcium channel, voltage-dependent, alpha 2/delta subunit 1FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Mixed
CACNB4Calcium channel, voltage-dependent, beta 4 subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transporters
Tissue enhanced
CACYBPCalcyclin binding proteinPlasma proteins
Predicted intracellular proteins
Nucleoplasm
Cytosol
Expressed in all
CADCarbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotaseCancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
NucleoplasmExpressed in all
CADM1Cell adhesion molecule 1Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Cell JunctionsMixed
CADPSCa++-dependent secretion activatorPlasma proteins
Predicted intracellular proteins
VesiclesGroup enriched
CALB2Calbindin 2Plasma proteins
Predicted intracellular proteins
CytosolTissue enhanced

« prev | Page of 76 | next »